Clinical Trial Update: 11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update reporting results from imaging studies using 11C-acetate and 18F-FDG PET/CT plus cardiac MRI in patients with pulmonary hypertensi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• 11C-Acetate (carbon-11 acetate)
• 18F-FDG (fluorodeoxyglucose F-18)

Snippet

Sponsor: University of Pennsylvania | Conditions: Pulmonary Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2019-02-05